The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...

A Massachusetts father faces federal charges for allegedly making inappropriate contact with a teen on a summer flight from ...

Mass General Brigham has announced the successful completion of another gene-edited pig kidney transplant, the first of a ...

The second person ever has received a transplant with a genetically modified pig kidney.

The first recipient of a gene-edited pig kidney died from cardiac causes 52 days after xenotransplantation. The world's first ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

New York has ordered a weeklong shutdown of all live bird markets in New York City, Westchester and Long Island after seven ...

Discover the latest breakthrough in organ transplantation as a 66-year-old man becomes the fourth person in the U.S. to receive a pig kidney transplant at Mass ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...